Gemcitabine: current status of phase I and II trials

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial.

ESMO open·2021

A decade of clinical development of PARP inhibitors in perspective.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit.

Clinical oncology (Royal College of Radiologists (Great Britain))·2017

The Influence of Donor and Recipient Gender Incompatibility on Corneal Transplant Rejection and Failure.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016

An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib.

Targeted oncology·2016